Terminated PHASE1 INTERVENTIONAL 1-arm NCT01589029

A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP) (ILARIS)

Sponsor: Novartis

Conditions Proliferative Diabetic Retinopathy

Updated 5 times since 2017 Last updated: Nov 23, 2015 Started: Apr 30, 2012 Primary completion: Nov 30, 2014 Completion: Nov 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The results of the interim analysis showed that the primary endpoint was not met

Other terminated trials from Novartis

See all terminations from Novartis

A PHASE1 clinical study on Proliferative Diabetic Retinopathy, this trial is terminated or withdrawn. The trial is conducted by Novartis and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novartis
PD Dr. med. Stephan Michels
University Hospital, Zürich

Data source: Triemli Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland